|
|
|
 |
Samsung is set to unveil the Galaxy S6, which is expected to sport a metal chassis. The smartphone will also have a variant with curved edges, reminiscent of the Galaxy Note Edge
Read More... |
| |
 |
Stratasys’ troubles continue in 2015, as the company lowers Q4 guidance and presents lower-than-expected outlook for 2015
Read More... |
| |
 |
Qualcomm confirms that more than 60 devices will be powered by the Snapdragon 810
Read More... |
| |
 |
Data revealed by IDC shows that all the biggest tablet manufacturers, except Lenovo, saw their market share decline in the tablet market
Read More... |
| |
 |
Alibaba has partnered with P2P lender LendingClub to help small businesses in the US secure financing for buying products from Chinese suppliers
Read More... |
| |
 |
Apple might need to be more vocal about its flagship smartwatch if it wants to build the right hype
Read More... |
| |
 |
MKM Partners analyst, Rob Sanderson, reiterates $105 price target on Facebook, while maintaining a Buy rating
Read More... |
| |
 |
Internet giants Google, Amazon, and Microsoft have reportedly made large payments to bypass the threat of Adblock on their sites
Read More... |
| |
 |
Walt Disney has reportedly delayed the opening of its Shanghai theme park. The entertainment resort is now scheduled to open in the first half of 2016 instead of December this year
Read More... |
| |
 |
RBC Capital analyst Mark Mahaney sees a higher probability of an upside variance for Twitter stock, based on factors such as user and revenue growth
Read More... |
| |
 |
Apple’s $1 billion unsecured notes offering has been been given a “AA+” rating
Read More... |
| |
 |
Alibaba Chairman says Ant Financial is still a “baby” and that he has not decided on a timetable for the offering
Read More... |
| |
 |
Spotify was widely rumored to have its IPO in 2015, but the odds for that deteriorated significantly after reports surfaced of an upcoming $500 million funding round, organized by Goldman Sachs
Read More... |
| |
 |
Google drops $399 annual subscription for the Google Earth Pro application
Read More... |
| |
 |
Alibaba has resolved its issues with the Chinese regulatory agencies to end the sale of counterfeit goods on its platforms
Read More... |
| |
 |
Bidness Etc brings you some of the latest rumors about possible new devices from Apple Inc.
Read More... |
| |
 |
Cantor Fitzgerald reveals expectations from Twitter’s 4Q results, ahead of its earnings release; holds a Buy rating on the stock with a $58 target price
Read More... |
| |
 |
Goldman Sachs maintains a “Conviction Buy” rating for both Dish and T-Mobile stocks, declaring Dish a “big winner”
Read More... |
| |
|
|
 |
GE has warned the Texas Workforce Commission that its Oil & Gas segment would be laying off 330 employees
Read More... |
| |
 |
Obama’s proposed budget proposes a 14% one-time tax on foreign earnings paired with a 19% tax on a ongoing basis and if passed, will likely hit Apple’s foreign profits hard
Read More... |
| |
 |
United Parcel Services reported 4Q financial results on Tuesday, beating revenue estimates and meeting EPS estimates
Read More... |
| |
|
|
 |
Bidness Etc provides a look at the key points from Cliffs Natural Resources’ fourth-quarter earnings release. The reasons that caused the stock to surge 12% in pre-market trade today are also discussed below
Read More... |
| |
|
|
 |
Office supplies giants, Staples and Office Depot, are in advanced talks of a merger, causing the shares to surge in early action today. The merger awaits regulatory approval from the Federal Trade Commission
Read More... |
| |
 |
Latest research shows that Tesla dealerships and service stores scored the highest marks in a survey valuating customer experience
Read More... |
| |
 |
Bidness Etc looks at speculations surrounding the specifications of Ford’s new performance hatchback. A picture of the vehicle has been leaked by Evo before the actual launch
Read More... |
| |
 |
The big box retailer is reaching a significant milestone this year by focusing on the smaller retail outlets instead of its conventional gigantic format, in a move to better fit denser urban areas
Read More... |
| |
 |
After receiving significant investor interest in its public listing, Shake Shack has declined more than 10% from its initial trading price
Read More... |
| |
 |
Global Equities Research has increased its price target on Tesla Motors stock on account of their belief that a strong dollar will be beneficial to the automaker’s sales and supply-chain mix
Read More... |
| |
 |
Under Armour Inc will report fourth-quarter earnings tomorrow. Bidness Etc provides an overview of what to expect from the apparel retailer’s quarterly results
Read More... |
| |
 |
The NYSE has announced that RadioShack will be delisted from the exchange, and that trading of the stock will be suspended immediately
Read More... |
| |
 |
Avon Products stock has received a downward revision in target price from $11.5 to $9 from an analyst at Credit Suisse.The analyst has reiterated a Buy rating. Bidness Etc discusses why the stock gained yesterday despite the reduced target price
Read More... |
| |
 |
Bidness Etc looks at Global Equities Research analyst Trip Chowdhry’s analysis that strong US currency will benefit Tesla Motors Inc
Read More... |
| |
 |
Wedbush analyst Michael Pachter reaffirmed his price target of $98 on GoPro stock, while reiterating an Outperform rating
Read More... |
| |
 |
With gasoline prices hovering around $2 per gallon, consumers are calculating the real cost of electric vehicles
Read More... |
| |
|
|
 |
Bidness Etc discusses the factors which caused Canadian Solar to acquire Recurrent Energy from Sharp Corporation for $265 million cash
Read More... |
| |
 |
Anadarko Petroleum reported fourth-quarter earnings yesterday. Bidness Etc looks at why the firm reported a quarterly loss of $395 million
Read More... |
| |
 |
Aurelius Capital continues to oppose Petrobras and accuses it of breaching the terms of the bond contracts and explains investors why Petrobras is most likely to default
Read More... |
| |
 |
Bidness Etc looks at the key takeaways from the fourth-quarter results of BP and the reasons why the oil giant reported a quarterly loss
Read More... |
| |
|
|
 |
AT&T’s credit rating has been cut following higher-than-expected bids at FCC auction. Analysts believe that Dish’s rating may be impacted, while Verizon remains unaffected
Read More... |
| |
 |
AT&T won 251 licenses at the FCC AWS-3 auction, and with $18.2 billion in provisional bids, was the largest spender at the spectrum auction
Read More... |
| |
 |
Verizon is set to sell assets worth $10 billion to pay off its enormous debt, according to a Wall Street Journal report
Read More... |
| |
|
|
 |
Top-line results announced for AbbVie’s two direct-acting antiviral treatment (2-DAA), in a Phase III study, for patients suffering from genotype 1b chronic hepatitis C infection has increased hopes for a potential approval to come soon
Read More... |
| |
 |
The FDA has assigned a breakthrough therapy status to Bluebird’s beta-thalassemia major drug LentiGlobin BB305
Read More... |
| |
 |
Sanofi’s Afrezza will be the only inhalable insulin on the US market, providing the company a competitive edge in the diabetes treatment market
Read More... |
| |
 |
Mylan has announced an $800 million agreement with Indian generic drug maker Famy Care, under which it will acquire the latter’s women’s health-care business
Read More... |
| |
 |
Ardelyx shares plunged as much as 32% during regular trading yesterday, after the company announced its lead kidney drug Tenapanor led to a higher-than-expected increase in diarrhea levels
Read More... |
| |
 |
Eli Lilly has received approval for its diabetes drug, developed in collaboration with Boehringer Ingelheim, shortly after the company announced that it will be shifting its focus towards its diabetes, oncology and immunology portfolio
Read More... |
| |
 |
Piper Jaffray reduces its price target on Arena Pharmaceuticals from $8 to $7.50, after restricting the price of new weight-loss drug, Belviq
Read More... |
| |
 |
The FDA has given the second Breakthrough Therapy Designation to Genentech's cancer immunotherapy MPDL3280A (anti-PDL1), for non-small cell lung cancer, which has increased the chances that the drug will get expedited approval this year
Read More... |
| |
|
|
 |
Bidness Etc looks at the factors which caused crude oil price to continue improving for the past three consecutive days, despite the announcement by BP and other oil majors to cut capital expenditure budget for 2015
Read More... |
| |
댓글 없음:
댓글 쓰기